BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36718855)

  • 1. ETS1 regulates NDRG1 to promote the proliferation, migration, and invasion of OSCC.
    Sheng X; Li X; Qian Y; Wang S; Xiao C
    Oral Dis; 2024 Apr; 30(3):977-990. PubMed ID: 36718855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
    de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
    Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
    Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
    World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
    Wang K; Jin J; Ma T; Zhai H
    Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway.
    Guo W; Qu Y; Yu Y; Li X; Liang Z; Wang Z; Hu T; Zhou S
    Aging (Albany NY); 2024 May; 16(10):9204-9215. PubMed ID: 38795388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
    Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
    Mao Y; Zhang W; Zhang R; Zuo J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Duan Q; Xu M; Wu M; Zhang X; Gan M; Jiang H
    Cancer Med; 2020 May; 9(9):3115-3129. PubMed ID: 32130788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
    Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
    Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
    Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX1/miR-429 feedback loop promotes growth, metastasis, and epithelial-mesenchymal transition in oral squamous cell carcinoma by targeting ITGB1.
    Lu X; Yang Y; Chen J; Zhao T; Zhao X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5289-5302. PubMed ID: 38277041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.